ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand

Eric J. Rellinger, Chandrasekhar Padmanabhan, Jingbo Qiao, Andrew Appert, Alex G. Waterson, Craig W. Lindsley, R. Daniel Beauchamp, Dai H. Chung

Research output: Contribution to journalArticle

Abstract

Ewing sarcomas are rare mesenchymal-derived bone and soft tissue tumors in children. Afflicted children with distant metastases have poor survival despite aggressive therapeutics. Epithelial-to-mesenchymal transition in epithelial carcinomas is associated with loss of E-cadherin and resistance to apoptosis. ML327 is a novel small molecule that we have previously shown to reverse epithelial-to-mesenchymal transition features in both epithelial and neural crest-derived cancers. Herein, we sought to evaluate the effects of ML327 on mesenchymal-derived Ewing sarcoma cells, hypothesizing that ML327 initiates growth arrest and sensitizes to TNF-related apoptosis-inducing ligand. ML327 induced protein expression changes, increased E-cadherin and decreased vimentin, consistent with partial induction of mesenchymal-to-epithelial transition in multiple Ewing Sarcoma cell lines (SK-N-MC, TC71, and ES-5838). Induction of epithelial features was associated with apoptosis, as demonstrated by PARP and Caspase 3 cleavage by immunoblotting. Cell cycle analysis validated these findings by marked induction of the subG0 cell population. In vitro combination treatment with TRAIL demonstrated additive induction of apoptotic markers. Taken together, these findings establish a rationale for further in vivo trials of ML327 in cells of mesenchymal origin both alone and in combination with TRAIL.

Original languageEnglish (US)
Pages (from-to)463-468
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume491
Issue number2
DOIs
StatePublished - Sep 16 2017
Externally publishedYes

Fingerprint

TNF-Related Apoptosis-Inducing Ligand
Ewing's Sarcoma
Epithelial-Mesenchymal Transition
Cells
Cadherins
Apoptosis
Neural Crest
Vimentin
Immunoblotting
Caspase 3
Tumors
Neoplasms
Cell Cycle
Bone
Tissue
Neoplasm Metastasis
Carcinoma
Bone and Bones
Cell Line
Molecules

Keywords

  • Apoptosis
  • Epithelial-to-mesenchymal transition
  • Ewing sarcoma
  • Isoxazole
  • ML327
  • TRAIL

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand. / Rellinger, Eric J.; Padmanabhan, Chandrasekhar; Qiao, Jingbo; Appert, Andrew; Waterson, Alex G.; Lindsley, Craig W.; Beauchamp, R. Daniel; Chung, Dai H.

In: Biochemical and Biophysical Research Communications, Vol. 491, No. 2, 16.09.2017, p. 463-468.

Research output: Contribution to journalArticle

Rellinger, Eric J. ; Padmanabhan, Chandrasekhar ; Qiao, Jingbo ; Appert, Andrew ; Waterson, Alex G. ; Lindsley, Craig W. ; Beauchamp, R. Daniel ; Chung, Dai H. / ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand. In: Biochemical and Biophysical Research Communications. 2017 ; Vol. 491, No. 2. pp. 463-468.
@article{47e1ece5556e445093e2ba8002af1cbe,
title = "ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand",
abstract = "Ewing sarcomas are rare mesenchymal-derived bone and soft tissue tumors in children. Afflicted children with distant metastases have poor survival despite aggressive therapeutics. Epithelial-to-mesenchymal transition in epithelial carcinomas is associated with loss of E-cadherin and resistance to apoptosis. ML327 is a novel small molecule that we have previously shown to reverse epithelial-to-mesenchymal transition features in both epithelial and neural crest-derived cancers. Herein, we sought to evaluate the effects of ML327 on mesenchymal-derived Ewing sarcoma cells, hypothesizing that ML327 initiates growth arrest and sensitizes to TNF-related apoptosis-inducing ligand. ML327 induced protein expression changes, increased E-cadherin and decreased vimentin, consistent with partial induction of mesenchymal-to-epithelial transition in multiple Ewing Sarcoma cell lines (SK-N-MC, TC71, and ES-5838). Induction of epithelial features was associated with apoptosis, as demonstrated by PARP and Caspase 3 cleavage by immunoblotting. Cell cycle analysis validated these findings by marked induction of the subG0 cell population. In vitro combination treatment with TRAIL demonstrated additive induction of apoptotic markers. Taken together, these findings establish a rationale for further in vivo trials of ML327 in cells of mesenchymal origin both alone and in combination with TRAIL.",
keywords = "Apoptosis, Epithelial-to-mesenchymal transition, Ewing sarcoma, Isoxazole, ML327, TRAIL",
author = "Rellinger, {Eric J.} and Chandrasekhar Padmanabhan and Jingbo Qiao and Andrew Appert and Waterson, {Alex G.} and Lindsley, {Craig W.} and Beauchamp, {R. Daniel} and Chung, {Dai H.}",
year = "2017",
month = "9",
day = "16",
doi = "10.1016/j.bbrc.2017.07.050",
language = "English (US)",
volume = "491",
pages = "463--468",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand

AU - Rellinger, Eric J.

AU - Padmanabhan, Chandrasekhar

AU - Qiao, Jingbo

AU - Appert, Andrew

AU - Waterson, Alex G.

AU - Lindsley, Craig W.

AU - Beauchamp, R. Daniel

AU - Chung, Dai H.

PY - 2017/9/16

Y1 - 2017/9/16

N2 - Ewing sarcomas are rare mesenchymal-derived bone and soft tissue tumors in children. Afflicted children with distant metastases have poor survival despite aggressive therapeutics. Epithelial-to-mesenchymal transition in epithelial carcinomas is associated with loss of E-cadherin and resistance to apoptosis. ML327 is a novel small molecule that we have previously shown to reverse epithelial-to-mesenchymal transition features in both epithelial and neural crest-derived cancers. Herein, we sought to evaluate the effects of ML327 on mesenchymal-derived Ewing sarcoma cells, hypothesizing that ML327 initiates growth arrest and sensitizes to TNF-related apoptosis-inducing ligand. ML327 induced protein expression changes, increased E-cadherin and decreased vimentin, consistent with partial induction of mesenchymal-to-epithelial transition in multiple Ewing Sarcoma cell lines (SK-N-MC, TC71, and ES-5838). Induction of epithelial features was associated with apoptosis, as demonstrated by PARP and Caspase 3 cleavage by immunoblotting. Cell cycle analysis validated these findings by marked induction of the subG0 cell population. In vitro combination treatment with TRAIL demonstrated additive induction of apoptotic markers. Taken together, these findings establish a rationale for further in vivo trials of ML327 in cells of mesenchymal origin both alone and in combination with TRAIL.

AB - Ewing sarcomas are rare mesenchymal-derived bone and soft tissue tumors in children. Afflicted children with distant metastases have poor survival despite aggressive therapeutics. Epithelial-to-mesenchymal transition in epithelial carcinomas is associated with loss of E-cadherin and resistance to apoptosis. ML327 is a novel small molecule that we have previously shown to reverse epithelial-to-mesenchymal transition features in both epithelial and neural crest-derived cancers. Herein, we sought to evaluate the effects of ML327 on mesenchymal-derived Ewing sarcoma cells, hypothesizing that ML327 initiates growth arrest and sensitizes to TNF-related apoptosis-inducing ligand. ML327 induced protein expression changes, increased E-cadherin and decreased vimentin, consistent with partial induction of mesenchymal-to-epithelial transition in multiple Ewing Sarcoma cell lines (SK-N-MC, TC71, and ES-5838). Induction of epithelial features was associated with apoptosis, as demonstrated by PARP and Caspase 3 cleavage by immunoblotting. Cell cycle analysis validated these findings by marked induction of the subG0 cell population. In vitro combination treatment with TRAIL demonstrated additive induction of apoptotic markers. Taken together, these findings establish a rationale for further in vivo trials of ML327 in cells of mesenchymal origin both alone and in combination with TRAIL.

KW - Apoptosis

KW - Epithelial-to-mesenchymal transition

KW - Ewing sarcoma

KW - Isoxazole

KW - ML327

KW - TRAIL

UR - http://www.scopus.com/inward/record.url?scp=85025467346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025467346&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2017.07.050

DO - 10.1016/j.bbrc.2017.07.050

M3 - Article

C2 - 28716733

AN - SCOPUS:85025467346

VL - 491

SP - 463

EP - 468

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -